Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements
- PMID: 12892712
- DOI: 10.1016/s1535-6108(03)00169-7
Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements
Erratum in
- Cancer Cell. 2003 Nov;4(5):415
Abstract
To identify human genes required for tumor cell growth, transcriptome-scale selection was used to isolate genetic suppressor elements (GSEs) inhibiting breast carcinoma cell growth. Growth-inhibitory GSEs (cDNA fragments that counteract their cognate gene) were selected from 57 genes, including known positive regulators of cell growth or carcinogenesis as well as genes that have not been previously implicated in cell proliferation. Many GSE-cognate genes encode transcription factors (such as STAT and AP-1) and signal transduction proteins. Monoclonal antibodies against a cell surface protein identified by GSE selection, neural cell adhesion molecule L1CAM, strongly inhibited the growth of several tumor cell lines but not of untransformed cells. Hence, selection for growth-inhibitory GSEs allows one to find potential targets for new anticancer drugs.
Similar articles
-
Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3231-5. doi: 10.1073/pnas.90.8.3231. Proc Natl Acad Sci U S A. 1993. PMID: 8386368 Free PMC article.
-
Genetic suppressor elements: new tools for molecular oncology--thirteenth Cornelius P. Rhoads Memorial Award Lecture.Cancer Res. 1995 Sep 15;55(18):4023-8. Cancer Res. 1995. PMID: 7664275
-
A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replication.Somat Cell Mol Genet. 1999 Jan;25(1):9-26. doi: 10.1023/b:scam.0000007136.49230.b3. Somat Cell Mol Genet. 1999. PMID: 10925700
-
Gene targets of antisense therapies in breast cancer.Expert Opin Ther Targets. 2002 Jun;6(3):375-85. doi: 10.1517/14728222.6.3.375. Expert Opin Ther Targets. 2002. PMID: 12223074 Review.
-
Potential clinical utility of monoclonal antibodies in the management of human carcinomas.Important Adv Oncol. 1985:170-92. Important Adv Oncol. 1985. PMID: 3916739 Review. No abstract available.
Cited by
-
L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.J Cell Biol. 2005 Feb 14;168(4):633-42. doi: 10.1083/jcb.200408051. J Cell Biol. 2005. PMID: 15716380 Free PMC article.
-
Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous gene COPZ1.Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12449-54. doi: 10.1073/pnas.1103842108. Epub 2011 Jul 11. Proc Natl Acad Sci U S A. 2011. PMID: 21746916 Free PMC article.
-
Large-scale exploration of growth inhibition caused by overexpression of genomic fragments in Saccharomyces cerevisiae.Genome Biol. 2004;5(9):R72. doi: 10.1186/gb-2004-5-9-r72. Epub 2004 Aug 31. Genome Biol. 2004. PMID: 15345056 Free PMC article.
-
Selection-subtraction approach (SSA): a universal genetic screening technique that enables negative selection.Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9327-32. doi: 10.1073/pnas.0403080101. Epub 2004 Jun 8. Proc Natl Acad Sci U S A. 2004. PMID: 15187233 Free PMC article.
-
Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion.Cancer Cell Int. 2010 Sep 15;10:34. doi: 10.1186/1475-2867-10-34. Cancer Cell Int. 2010. PMID: 20840789 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
